NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)

קרןNational Institute on Drug Abuse/NIH
סוגResearch Grants
תאריך אחרון25/07/2019
תאריכים נוספים25/07/2020
פקולטהLife Sciences, Medicine, Social Sciences

The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use.  


Funding: $1,000,000 per year

Duration: UG3 2 years; UH3 3 years 


Research Authority due dates: 10 days prior to submission

LOI (encouraged) due date: 25.6.18, 25.6.19, 25.6.20

Full proposal due dates: 25.7.18, 25.7.19, 25.9.20

קבצים מצורפים
עדכון אחרוןעדכון אחרון: 29/01/2018
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive